Premium
R‐CHOP +/‐RADIOTHERAPY IN NON‐BULKY LIMITED‐STAGE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FINAL RESULTS OF THE PROSPECTIVE RANDOMIZED PHASE III 02‐03 TRIAL FROM THE LYSA/GOELAMS
Author(s) -
Lamy T.,
Damaj G.,
Soubeyran P.,
Gyan E.,
Legouill S.,
Cartron G.,
Boubdallah K.,
Gressin R.,
Cornillon J.,
Banos A.,
Ledu K.,
Benchalal M.,
Moles M.,
Fleury J.,
Godmer P.,
Maisonneuve H.,
Deconninck E.,
Laribi K.,
Marolleau J.,
Tournilhac O.,
Deviller A.,
Fest T.,
Colombat P.,
Costes V.,
Bene M.,
Delwail V.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_118
Subject(s) - medicine , chop , diffuse large b cell lymphoma , randomization , rituximab , randomized controlled trial , gastroenterology , surgery , radiation therapy , lymphoma